Shares of Faron Pharmaceuticals Oy (LON:FARN) hit a new 52-week high on Wednesday . The stock traded as high as GBX 870 ($11.24) and last traded at GBX 870 ($11.24), with a volume of 4,000 shares. The stock had previously closed at GBX 800 ($10.33).
Separately, Panmure Gordon restated a “buy” rating and set a GBX 723 ($9.34) price objective on shares of Faron Pharmaceuticals Oy in a research report on Wednesday, September 6th.
The firm’s market capitalization is GBX 237.42 million. The company’s 50 day moving average is GBX 705.90 and its 200-day moving average is GBX 673.12.
In related news, insider Jonathan Knowles purchased 63,000 shares of the firm’s stock in a transaction dated Friday, September 8th. The stock was acquired at an average price of GBX 725 ($9.36) per share, with a total value of £456,750 ($589,887.64).
Faron Pharmaceuticals Oy Company Profile
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.